Drug intelligence / Profile preview

Tyrophagus putrescentiae extract

Development stage
Unknown
Lead developer
National Institute for Biological Standards and Control
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Epicutaneous, Intradermal, Intranasal, Inhalation
01

Overview

Tyrophagus putrescentiae extract is a biological preparation derived from the storage mite, *Tyrophagus putrescentiae*, also known as the mould or cheese mite. [14] This mite is a significant source of indoor allergens, and sensitization can lead to allergic diseases including asthma, allergic rhinitis, and atopic dermatitis. [8, 11] The extract contains a complex mixture of allergenic proteins, such as Tyr p 2, Tyr p 8, and Tyr p 13, which can trigger Type I hypersensitivity reactions in susceptible individuals by binding to IgE antibodies. [2, 6, 13] The extract is used for in-vitro and in-vivo diagnostic testing to identify sensitization to this specific mite. [5] Furthermore, it is used as the active ingredient in allergen-specific immunotherapy (AIT), a disease-modifying treatment for allergic conditions. [4, 18] AIT involves the repeated administration of the allergen extract to induce immunological tolerance, which can lead to a long-term reduction in allergy symptoms by shifting the immune response from an allergic Th2 profile towards a more regulated state. [4, 18]

Other names
Mould mite extractStorage mite extractCheese mite extract

Beyond the preview

Go deeper on Tyrophagus putrescentiae extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tyrophagus putrescentiae extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call